United States - English - NLM (National Library of Medicine)

akorn - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix - injection with diluent - 250 mcg - active: cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix excipient: mannitol water for injection - prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cetrorelix acetate 3.12mg equivalent to 3.00 mg cetrorelix - injection with diluent - 3 mg - active: cetrorelix acetate 3.12mg equivalent to 3.00 mg cetrorelix excipient: mannitol water for injection - prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Israel - English - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

Israel - English - Ministry of Health

merck serono ltd - cetrorelix as acetate - powder and solvent for solution for injection - cetrorelix as acetate 0.25 mg/vial - cetrorelix - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

United States - English - NLM (National Library of Medicine)

emd serono, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix 0.25 mg in 1 ml - cetrotide® (cetrorelix acetate for injection) is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrotide® (cetrorelix acetate for injection) is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - cetrorelix (as acetate) - ovulation; ovulation induction - pituitary and hypothalamic hormones and analogues - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte-pick-up and assisted-reproductive techniques.in clinical trials, cetrotide was used with human menopausal gonadotropin (hmg), however, limited experience with recombinant follicule-stimulating hormone (fsh) suggested similar efficacy.

Canada - English - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 0.25mg - cetrorelix (cetrorelix acetate) 0.25mg - gonadotropin-releasing hormone antagonists

Canada - English - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 3mg - cetrorelix (cetrorelix acetate) 3mg - gonadotropin-releasing hormone antagonists